Everything Is Changing, and Now There’s a Chance It’s Changing for the Better
November 28–29, 2018 New York, NY
NEW YORK (November 8, 2018) – Forbes will gather the biggest names in healthcare at Jazz at Lincoln Center in New York City on November 28 and 29, 2018, for the seventh annual Forbes Healthcare Summit.
Billionaire John Arnold will explain why he has made injecting market forces into drug pricing his philanthropic cause. Legendary venture capitalist John Doerr will explain what healthcare can learn from tech about setting goals and choosing metrics. The chief executives of Novartis, Bristol-Myers Squibb, CVS Health, Humana, Takeda and the Walgreens Boots Alliance will address some of the biggest issues facing their businesses – including a session looking under the hood of two of the biggest pending mergers in the healthcare sector. And that’s before deep dives into the most promising cancer drugs and the hottest biotechnology companies. All told, representatives of companies with an aggregate $1.4 trillion in market value will assemble on one stage.
“In healthcare, it always seems that everything is changing,” says Matthew Herper, Forbes’ Senior Editor for Pharma Healthcare. “Now there’s evidence that it is changing for the better. Obviously, scientific innovation is happening at a rate we’ve never seen before. But we’re also seeing changes in the way companies think about health.”
One example of the changing culture will come from a session in which top executives from health insurers and hospital systems talk about how so-called social determinants of health – things like food, rent, and transportation – are as important as technology in keeping patients healthy. And Forbes will assemble a group of healthcare experts who have seen the system up close as caregivers for patients — including Lucy Kalanithi, widow of Paul Kalanithi, the author of the bestseller When Breath Becomes Air – to brainstorm about how the healthcare system could be made better. There will also be a wealth of stories from entrepreneurs, including Nat Turner, the chief executive of Flatiron Health, which was purchased by Roche earlier this year at a valuation of $2.1 billion.
Speakers at the summit will include:
Data Dreamers: John Doerr, Chairman, Kleiner Perkins; Jennifer Esposito, Worldwide General Manager, Health and Life Sciences Group, Intel Corporation; Colin Hill, Chief Executive Officer, Chairman Cofounder, GNS Healthcare; Sam Marwaha, Senior Partner Managing Director, The Boston Consulting Group (BCG); Joanna Shields, Chief Executive, Benevolent AI; Nat Turner, Chief Executive Officer, Flatiron Health
Bio Visionaries: Josh Bilenker, President Chief Executive Officer, Loxo Oncology; David Chang, President, Chief Executive Officer Cofounder, Allogene Therapeutics, Doug Ingram, Chief Executive Officer, Sarepta Therapeutics; Jeffrey Jonas, Chief Executive Officer, Sage Therapeutics; Cigall Kadoch, Assistant Professor, Dana-Farber Cancer Institute, Cofounder, Foghorn Therapeutics; Jeffrey Leiden, Chief Executive Officer, Vertex Pharmaceuticals, John Maraganore, Chief Executive Officer, Alnylam Pharmaceuticals; Reshma Shetty, Cofounder, Ginkgo Bioworks
Reimagineers: John Arnold, Co-Chair, Laura and John Arnold Foundation; Peter Bach, Director, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center; Lucy Kalanithi, Clinical Assistant Professor of Medicine, Stanford University School of Medicine; Larry Merlo, President Chief Executive Officer, CVS Health; Robert Nelson, Cofounder Managing Director, ARCH Venture Partners; Stefano Pessina, Executive Vice Chairman Chief Executive Officer, Walgreens Boots Alliance; Surbhi Sarna, Founder Chief Executive Officer, nVision Medical,
Value Makers: Bruce Broussard, Chief Executive Officer, Humana; Michael Dowling, President Chief Executive Officer, Northwell Health; David Feinberg, President Chief Executive Officer, Geisinger; Steve Miller, Senior Vice President Chief Medical Officer, Express Scripts; Barry Ostrowsky, President Chief Executive Officer, RWJBarnabas Health
Pharma Innovators: Giovanni Caforio, Chief Executive Officer, Bristol-Myers Squibb; Daniel O’Day, Chief Executive Officer, Roche Pharmaceuticals; Roger Perlmutter, Executive Vice President President, Merck Research Laboratories; Christi Shaw, Senior Vice President, Eli Lilly and Company and President, Lilly Bio-Medicines; Stephen Ubl, Chief Executive Officer, PhRMA; Vas Narasimhan, Chief Executive Officer, Novartis; Christophe Weber, President Chief Executive Officer, Takeda Pharmaceutical Company
Attendees of the summit include medical professionals, doctors, hospital executives, academics, researchers, venture capitalists, pharmaceutical firms, policymakers, philanthropists and future leaders.
For a look at the Forbes Healthcare Summit 2018 agenda, please visit: www.forbes.com/forbes-live/event/healthcare-2018/
Presenting Level sponsors for the 2018 Healthcare Summit include The Boston Consulting Group (BCG), Intel Corporation and The Pharmaceutical Research and Manufacturers of America (PhRMA), representing America’s biopharmaceutical companies. CVS Health, Northwell Health, RWJBarnabas Health and Sanofi are Partner Level sponsors. City of Hope and Wells Fargo are Supporting Level sponsors.
Forbes Media Relations Contacts
Christina Vega at firstname.lastname@example.org or 212.206.5155
Laura Brusca at LBrusca@forbes.com or 212.367.4874